Global Wilson's Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Wilson's Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

According to our (Global Info Research) latest study, the global Wilson's Disease market size was valued at US$ 220 million in 2023 and is forecast to a readjusted size of USD 290 million by 2030 with a CAGR of 4.1% during review period.

The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.

This report is a detailed and comprehensive analysis for global Wilson's Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Wilson's Disease market size and forecasts, in consumption value ($ Million), 2019-2030

Global Wilson's Disease market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Wilson's Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Wilson's Disease market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Wilson's Disease

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Wilson's Disease market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, ANI Pharmaceuticals, APOTEX, Tsumura, Sinepharm, Taj Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Wilson's Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Wilson's Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Trientine
Penicillamine
Others

Market segment by Application
Hospital
Drugs Stores
Others

Market segment by players, this report covers
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Wilson's Disease product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Wilson's Disease, with revenue, gross margin, and global market share of Wilson's Disease from 2019 to 2024.

Chapter 3, the Wilson's Disease competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Wilson's Disease market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Wilson's Disease.

Chapter 13, to describe Wilson's Disease research findings and conclusion.